Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you are unlikely to be protected if something goes wrong.
Take two mins to learn more
17 Feb 2026
In today’s world of accelerating change and mounting global challenges—from climate pressure to resource scarcity, from healthcare disparities to supply chain fragility—the need for transformative technologies has never been more urgent. Yet, for many years, investors were told they had to make a choice: pursue financial returns or pursue meaningful impact.
At EverQuest Capital, we believe that choice is outdated. We operate on a new thesis: purpose and profit are no longer at odds—they are increasingly inseparable. In fact, some of the most attractive commercial opportunities now lie in companies tackling the hardest problems through breakthrough innovation. Welcome to the world of high-impact deep tech.
Deep MakeTech: A New Industrial Paradigm
The type of innovation we back at EverQuest sits at the intersection of deep science and advanced manufacturing—a space we define as Deep MakeTech. This term captures our investment sweet spot: early-stage ventures rooted in fundamental science, but with the potential (and ambition) to scale into industrial-strength solutions.
These are not apps, marketplaces, or software-as-a-service platforms. These are companies built on technical IP—novel materials, synthetic biology, chemical processes, precision engineering—that are transforming how we make things: from proteins to medical devices, from recycled metals to printed electronics.
But unlike traditional industrial innovation, Deep MakeTech isn’t just about efficiency. It’s about impact. It’s about reducing carbon, conserving resources, enabling human health, and building systems that are sustainable by design. And most importantly, it’s about doing all of that while creating substantial long-term value for investors.
Why Impact and Return Are No Longer a Trade-off
In the past, "impact investing" was often seen as a niche category—philanthropy-adjacent, or limited to lower-yield social enterprises. But this perception is rapidly shifting. Today, deep tech is becoming the engine room of global impact, and investors are taking note. Here’s why:
Global market pull: Governments, corporates, and consumers are all demanding cleaner, safer, more sustainable technologies. Regulation is tightening. Legacy industries are struggling to adapt. That creates a powerful market need for new solutions.
Scientific maturity: Years of academic research are now producing breakthroughs that are commercially viable, not just theoretically interesting. And with better infrastructure, these can be productised faster than ever before.
Defensibility and differentiation: Unlike software that can be replicated or disrupted overnight, deep tech companies are often built around patented processes, complex systems, and years of scientific know-how. This creates lasting value.
At EverQuest, we see this convergence as a unique investment window: technologies with real-world impact and the potential for venture-scale growth.
Our Portfolio: Value Creation in Action
Our portfolio illustrates this philosophy—companies solving critical challenges, with clear paths to scale and strong IP moats.
Descycle: Revolutionising E-Waste and Critical Mineral Recovery
Electronic waste is the fastest-growing waste stream globally—and one of the most under-recycled. Descycle uses proprietary deep eutectic solvents (DES) to extract valuable metals like gold, palladium, and copper from old electronics without high heat or toxic chemicals. This approach is cleaner, cheaper, and more scalable than conventional methods.
For investors, the value is clear: Descycle is not just a recycling business. It’s a critical minerals strategy, aligned with national industrial security agendas and global ESG mandates. It meets a growing supply chain need with a proprietary, proven technology.
MarraBio: Enabling the Future of Cultivated Meat and Biomanufacturing
The cultivated meat industry is growing rapidly, but one major hurdle remains: the cost and inconsistency of animal-derived proteins used in cell culture. MarraBio engineers these proteins recombinantly, offering standardised, scalable inputs for both food and therapeutic applications.
Their work sits at the intersection of food tech, biotech, and clean manufacturing—enabling more ethical, sustainable, and efficient production systems for the future. The commercial upside? Serving a rapidly expanding global market in food and pharmaceuticals with repeatable, defensible IP.
Qkine and Q5D: Accelerating Advanced Therapeutics and Automated Manufacturing
Qkine produces ultra-pure proteins used in regenerative medicine, drug discovery, and cell therapies—helping to improve reproducibility and reduce batch failure in critical R&D and clinical settings.
Q5D automates the 3D wiring of electronics directly into products—removing manual assembly bottlenecks in aerospace, automotive, and defense.
Each of these companies addresses a system-level challenge in how complex technologies are made, tested, or scaled—precisely the kind of high-leverage impact we seek.
Enabling Scale: The CPI Partnership Advantage
Backing deep tech ventures is not just about capital—it’s about capacity. Many promising companies fail not because the science doesn’t work, but because they lack the facilities, people, and process to scale it up.
That’s why EverQuest has built a close, strategic partnership with the Centre for Process Innovation (CPI)—the UK’s foremost innovation centre for process and product scale-up. Through CPI, our portfolio companies gain access to:
State-of-the-art labs and pilot-scale manufacturing spaces
Engineering, materials, and bioscience experts for real-time problem solving
Infrastructure to validate, test, and optimise at industrial levels
This ecosystem accelerates time to market, reduces technical risk, and enhances capital efficiency. It’s a force multiplier—giving early-stage deep tech companies the chance to perform like mature ones, much earlier in their lifecycle.
Accessing the Opportunity: The EIS Advantage
For individual investors, deep tech is no longer the exclusive realm of institutional capital. Through the EverQuest EIS Fund, we offer qualified investors access to a diversified portfolio of high-impact startups, with the added benefit of Enterprise Investment Scheme (EIS) tax reliefs.
These include:
30% income tax relief on eligible investments
Capital gains tax deferral when gains are reinvested
Tax-free capital gains on qualifying shares held for at least three years
Loss relief that offsets downside exposure
Inheritance tax exemption after two years
For impact-driven investors seeking asymmetric upside and real-world relevance, the EIS structure offers a compelling way to align returns with purpose—while mitigating early-stage risk.
Looking Ahead: Investing in the Next Industrial Chapter
The world is not short on challenges. But what it needs—and what investors increasingly seek—are solutions with substance. Not just ideas, but deployable technologies. Not just growth, but growth that matters.
At EverQuest Capital, our mission is to find, fund, and foster those solutions. By investing where the science is strong, the impact is urgent, and the infrastructure is in place, we are creating a portfolio built not just for the next funding cycle—but for the next industrial age.
If you're looking to back companies with the power to shape industries and improve lives, you're not choosing between purpose and profit. You're choosing both. You're choosing to invest where it matters.